AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19509107
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human TSH injections (0.9 mg im per 2 consecutive days) - group B
Trial: 10919900
Drug: Artificial tears
RxNorm normalized name: Artificial Tears
DrugBank: Polyethylene glycol 400 (DB11077)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artificial tears four times daily
Trial: 2697690
Drug: Glycine fortified
RxNorm normalized name: Glycine
DrugBank: Glycine (DB00145)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glycine fortified oral rehydration solution (ORS)
Trial: 21529904
Drug: Maintenance low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Maintenance low-dose paclitaxel 40 mg/m²/week for 24 weeks
Trial: 21529904
Drug: Maintenance low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Maintenance low-dose paclitaxel
Trial: 9047153
Drug: Control patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control patients receiving OKT3 therapy
Trial: 27127998
Drug: Fluticasone furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone furoate (FF) 800 mcg
Trial: 27127998
Drug: Vilanterol (VI)
RxNorm normalized name: Vilanterol
DrugBank: Vilanterol (DB09082)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vilanterol (VI) 100 mcg
Trial: 16940830
Drug: Twice-daily amoxicillin
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily amoxicillin
Trial: 11015795
Drug: Sterile saline
RxNorm normalized name: Aqua Care Sterile Saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sterile saline injection (placebo; n = 589 in 1997-1998; n = 604 in 1998-1999)
Trial: 7478692
Drug: Local anesthetic
RxNorm normalized name: Local anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anesthetic cream
Trial: 27633651
Drug: Control cream
RxNorm normalized name: BENZOYL PEROXIDE 3 mg in 60 mL TOPICAL LIQUID [Acnecare Dermacontrol Cream]
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control cream
Trial: 6991103
Drug: Pseudomonas vaccine
RxNorm normalized name: Pseudomonas aeruginosa
DrugBank: Pseudomonas aeruginosa (DB19284)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pseudomonas vaccine
Trial: 17679725
Drug: Centrally assessed
RxNorm normalized name: Rauwolfia alkaloids, centrally acting antiadrenergic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Centrally assessed hormone receptor status
Trial: 1980464
Drug: Flurazepam 30
RxNorm normalized name: flurazepam 30 mg oral capsule
DrugBank: Flurazepam (DB00690)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flurazepam 30 mg
Trial: 23756569
Drug: Non-fermented dairy
RxNorm normalized name: Beano Dairy Defense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-fermented dairy diet (butter, cream, ice cream)
Trial: 21774289
Drug: Intracameral triamcinolone
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracameral triamcinolone acetonide and gentamicin injections followed by topical tobramycin eye drops four times daily for one week (IC TA group, n=30)
Trial: 3136064
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg disopyramide
Trial: 3136064
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg flecainide
Trial: 29153295
Drug: 15 mL
RxNorm normalized name: ethanol 0.15 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mL of 37.5 mg ropivacaine plus 40 mg methylprednisolone (active group, n=49)
Trial: 11994249
Drug: JTT-705 900
RxNorm normalized name: JTT-251
DrugBank: JTT-251 (DB18174)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JTT-705 900 mg
Trial: 7613531
Drug: Antiandrogen therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiandrogen therapy
Trial: 15459137
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (500 microg b.i.d. by inhalation and 100 microg intranasally once daily)
Trial: 21962063
Drug: Sildenafil citrate
RxNorm normalized name: Sildenafil Citrate
DrugBank: Sildenafil (DB00203)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sildenafil citrate 50 mg three times daily
Trial: 3210111
Drug: Erythromycin treatment
RxNorm normalized name: Erythromycin
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin treatment
Trial: 30547316
Drug: F14512 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: F14512 at dose level 5 mg/m2/day
Trial: 25851025
Drug: Traditional Iranian
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional Iranian Pharmacy formulation
Trial: 29718143
Drug: Covering empirical
RxNorm normalized name: Canker Cover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Covering empirical antibiotic treatment (EAT)
Trial: 15161956
Drug: Tacrolimus for
RxNorm normalized name: tacrolimus Granules for Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacrolimus for cyclosporin (C(0): 5-10 ng/ml)
Trial: 15161956
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of standard therapy (C(0): 163 ng/ml (145-215 ng/ml))
Trial: 2951158
Drug: Acarbose 100
RxNorm normalized name: acarbose 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose 100 mg thrice daily
Trial: 8223138
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg levodropropizine
Trial: 28192113
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg dihydrocodeine
Trial: 8113478
Drug: Problem-Solving Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Problem-Solving Therapy (PST)
Trial: 24326106
Drug: Verteporfin photodynamic
RxNorm normalized name: Verteporfin
DrugBank: Verteporfin (DB00460)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Verteporfin photodynamic therapy (vPDT) (group III, n = 55)
Trial: 15841781
Drug: Lidocaine hydrochloride
RxNorm normalized name: Lidocaine Hydrochloride
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine hydrochloride gel (Group 2)
Trial: 15157139
Drug: Treatment impact
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment impact
Trial: 21199833
Drug: Satavaptan 25
RxNorm normalized name: Satavaptan
DrugBank: Satavaptan (DB14923)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Satavaptan 25 mg/day in CHF patients
Trial: 18001442
Drug: Oral clindamycin
RxNorm normalized name: clindamycin Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral clindamycin
Trial: 23946318
Drug: eletriptan 40
RxNorm normalized name: eletriptan 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eletriptan 40 mg (ELE-40)
Trial: 2419384
Drug: Allergen immunotherapy
RxNorm normalized name: Allergen immunotherapy extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allergen immunotherapy with cat- and dog-dander extracts
Trial: 29210957
Drug: Caffeine gum
RxNorm normalized name: caffeine Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine gum (CAF) 400 mg; 4.1 ± 0.5 mg·kg
Trial: 7051805
Drug: L‐PAM
RxNorm normalized name: Melphalan
DrugBank: Melphalan (DB01042)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L‐PAM
Trial: 8855175
Drug: Interferon alfa
RxNorm normalized name: Interferon alfa
DrugBank: Interferon alfa (DB05258)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa (IFN-alpha) 5 MU three times weekly for 6 months
Trial: 12562140
Drug: Substance P
RxNorm normalized name: Substance P
DrugBank: Substance P (DB19198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Substance P receptor antagonists (SPAs) aprepitant (MK‐0869) and compound A
Trial: 31833059
Drug: 12-hour maintenance
RxNorm normalized name: cenobamate
DrugBank: Cenobamate (DB06119)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 12-hour maintenance dose of magnesium sulfate (MgSO4)
Trial: 8403157
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam (0.5 mg.kg‐1) premedication, all groups
Trial: 22234000
Drug: parecoxib 40
RxNorm normalized name: Parécoxib
DrugBank: Parecoxib (DB08439)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: parecoxib 40 mg IV
Trial: 22234000
Drug: ketoprofen 100
RxNorm normalized name: ketoprofen 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ketoprofen 100 mg IV
Trial: 26427279
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of torasemide
Trial: 26427279
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of spironolactone
Trial: 31842852
Drug: Local ingredients-based
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local ingredients-based supplement (LIBS) - 100 g of LIBS plus 25.2 g of sugar with 8 ml oil
Trial: 23657969
Drug: Tibetan Sound
RxNorm normalized name: ibritumomab tiuxetan
DrugBank: Ibritumomab tiuxetan (DB00078)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Tibetan Sound Meditation (TSM) - two weekly sessions for 6 weeks
Trial: 30080227
Drug: Social-based activities
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social-based activities (n=47), 60 minutes/session, twice per week for 24 weeks
Trial: 1936753
Drug: Acute administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acute administration of verapamil 160 mg
Trial: 1936753
Drug: Chronic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chronic treatment of verapamil 240 mg/day for six months
Trial: 8919573
Drug: Low dosage
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dosage ECT
Trial: 8919573
Drug: High dosage
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dosage ECT
Trial: 16518530
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg atorvastatin
Trial: 22206075
Drug: RT001 Botulinum
RxNorm normalized name: CLOSTRIDIUM BOTULINUM
DrugBank: Clostridium botulinum (DB14223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RT001 Botulinum Toxin Type A Topical Gel
Trial: 11450599
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy with cat epithelial extract
Trial: 22484874
Drug: Composite resin
RxNorm normalized name: Benzoin resin
DrugBank: Benzoin resin (DB11222)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Composite resin (34% Tooth Conditioner Gel + Adper Single Bond 2 + Z100)
Trial: 15297790
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) treatment (16-32 mg/kg/day) for 6 days
Trial: 1586708
Drug: Higher-dose methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Higher-dose methylprednisolone (HDM)
Trial: 3289598
Drug: Atenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 50 mg twice daily alone
Trial: 21273177
Drug: Concurrent docetaxel
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concurrent docetaxel (75 mg/m² I.V.) followed by bortezomib (1.6 mg/m² I.V. on days 1 and 8)
Trial: 21273177
Drug: Sequential docetaxel
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sequential docetaxel (75 mg/m² I.V.) followed by bortezomib (1.6 mg/m² I.V. on days 2 and 8)
Trial: 19446148
Drug: 70 mg
RxNorm normalized name: silybin 70 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 70 mg weekly oral alendronate
Trial: 23047956
Drug: Patient ratings
RxNorm normalized name: Aratinga erythrogenys feather extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient ratings of treatment
Trial: 9672330
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg daily for 8 weeks
Trial: 18303097
Drug: Intermediate dose
RxNorm normalized name: Prevotella intermedia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermediate dose (120 mcg ipratropium bromide and 600 mcg of salbutamol using metered dose inhaler (MDI) and spacer)
Trial: 8386779
Drug: Intracorporeal injections
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracorporeal injections with sodium bicarbonate (0.03 mEq.)
Trial: 21537127
Drug: DEB loaded
RxNorm normalized name: triclosan
DrugBank: Triclosan (DB08604)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: DEB loaded with 50 mg doxorubicin
Trial: 17416113
Drug: Gliclazide 80
RxNorm normalized name: gliclazide 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gliclazide 80 mg tablet from EMS Indústria Farmacêutica Ltda.
Trial: 16948483
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (VC) 3 g/d
Trial: 9366314
Drug: Potassium-magnesium citrate
RxNorm normalized name: potassium magnesium aspartate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium-magnesium citrate (42 mEq. potassium, 21 mEq. magnesium, and 63 mEq. citrate) daily for up to 3 years
Trial: 12160194
Drug: Eplerenone 25
RxNorm normalized name: eplerenone 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone 25 mg twice daily
Trial: 31926085
Drug: Amoxicillin prescription
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin prescription in adults
Trial: 19453319
Drug: Proton Pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton Pump Inhibitors
Trial: 2906696
Drug: Intrarenal infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrarenal infusion of an alpha 1‐antagonist
Trial: 2906696
Drug: Blockade of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blockade of alpha 2‐receptors
Trial: 12448241
Drug: Cefazolin single-dose
RxNorm normalized name: Cefazolin
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefazolin single-dose regimen
Trial: 10438352
Drug: Zidovudine and
RxNorm normalized name: zidovudine and lamivudine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidovudine and lamivudine (two-drug therapy)
Trial: 21822907
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no OTRa administration).
Trial: 1687407
Drug: Intravenous beta-blockers
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous beta-blockers
Trial: 17721096
Drug: Interleukin-2 therapy
RxNorm normalized name: Interleukin-2 aldesleukin
DrugBank: Aldesleukin (DB00041)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interleukin-2 therapy (subcutaneous IL-2, median of ten 5-day cycles)
Trial: 7648827
Drug: Intravenous insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous insulin (1.8U over 15 min)
Trial: 8006126
Drug: Progesterone supplementation
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Progesterone supplementation (i.m. progesterone at a daily dose of 25‐50 mg for 14 days)
Trial: 15380907
Drug: No supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No supplement
Trial: 26543357
Drug: Linseed oil
RxNorm normalized name: linseed oil
DrugBank: Linseed oil (DB11357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linseed oil supplementation (3 g/day)
Trial: 24927607
Drug: Filibuvir 300
RxNorm normalized name: Filibuvir
DrugBank: Filibuvir (DB11878)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Filibuvir 300 mg BID plus pegIFN/ribavirin
Trial: 1293261
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg preservative-free morphine
Trial: 22912450
Drug: YDC treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: YDC treatment
Trial: 10450540
Drug: Mud packs
RxNorm normalized name: aminophylline / ephedrine hydrochloride / guaifenesin / phenobarbital Oral Tablet [Mudrane GG]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mud packs combined with antidepressant treatment (trazodone)
Trial: 10338176
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg tramadol
Trial: 8389738
Drug: Captopril (C)
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril (C) 25, 50, or 100 mg b.i.d.
Trial: 19064627
Drug: Rabies vaccine
RxNorm normalized name: RABIES VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabies vaccine
Trial: 8330828
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of butylscopolamine bromide i.v. (BSB)
Trial: 31623758
Drug: 12-month DAPT
RxNorm normalized name: DAPT
DrugBank: Diaminopropanol tetraacetic acid (DB12362)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12-month DAPT followed by 12-month aspirin monotherapy
Trial: 31290965
Drug: Esketamine 84
RxNorm normalized name: ESKETAMINE
DrugBank: Esketamine (DB11823)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Esketamine 84 mg plus oral antidepressant
Trial: 16971315
Drug: Tetracycline 1
RxNorm normalized name: tetracycline 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetracycline 1 g daily for 1 month, then 500 mg daily for 2 months
Trial: 22460183
Drug: Corticosteroids and
RxNorm normalized name: Corticosteroids and mydriatics in combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroids and azathioprine (3 intravenous pulses of methylprednisolone 1 g at months 1, 3, and 5; oral prednisone 0.5 mg/kg every other day plus azathioprine 1.5 mg/kg/day for 6 months, followed by oral prednisone 0.2 mg/kg every other day plus azathioprine 50 mg/day for a further 6 months)
Trial: 11417034
Drug: Prepackaged antimalarial
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prepackaged antimalarial drugs
Trial: 8275216
Drug: Dietary intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary intervention consisting of a diet with 28% of calories as total fat (< 8% saturated fat, up to 9% polyunsaturated fat, 11% monounsaturated fat) and dietary cholesterol intake less than 75 mg/1000 kcal (< 150 mg/d)
Trial: 8225624
Drug: Amoxicillin-clavulanic acid
RxNorm normalized name: amoxicillin / clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin-clavulanic acid (2.2 g)
Trial: 20839290
Drug: Denosumab (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab (60 mg subcutaneous injections every 6 months for 3 years)
Trial: 3307888
Drug: Grenz rays
RxNorm normalized name: Ray Dol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grenz rays in a total dose of 900 rad (9 Gy) given in three equal doses at 21‐day intervals
Trial: 26060122
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg prasugrel loading dose (LD) followed by an additional 30 mg prasugrel at the time of PCI
Trial: 3908435
Drug: oral acyclovir
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: oral acyclovir 200 mg five times daily for five days
Trial: 19655244
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 supplementation at 50,000 IU weekly for 12 weeks
Trial: 20670096
Drug: Intranasal estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal estradiol (300 μg/day estradiol hemihydrate)
Trial: 25933183
Drug: DTwP-HepB+Hib vaccine
RxNorm normalized name: hepatitis B surface antigen vaccine
DrugBank: Hepatitis B Vaccine (Recombinant) (DB11627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTwP-HepB+Hib vaccine (Pentavac)
Trial: 30170781
Drug: Multi-strain probiotics
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-strain probiotics (Ecologic®Barrier) 2.5 × 10^9 cfu/g, twice daily for 6 months
Trial: 16763405
Drug: Radiotherapy combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy combined with chemotherapy including anthracycline